All Stories

  1. An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease
  2. Safety, pharmacokinetics, pharmacogenomics and QT concentration−effect modelling of the SirT1 inhibitor selisistat in healthy volunteers
  3. Oxidative stress in drug discovery: A panel of in vitro toxicity markers
  4. Straightforward Recursive Partitioning Model for Discarding Insoluble Compounds in the Drug Discovery Process
  5. β‐Cyclodextrin Reduces Bioavailability of Orally Administered [3H]Benzo[a]pyrene in the Rat
  6. Tyrosine transport is regulated differently in patients with schizophrenia
  7. Synthesis of meta-iodobenzyl [11C]guanidine
  8. Synthesis of meta-iodobenzyl [11C]guanidine
  9. 11C-harmine as a tracer for monoamine oxidase a (MAO-A): In vitro and in vivo studies
  10. On-line production of [11C]cyanogen bromide
  11. Differential effects of levodopa on dopaminergic function in early and advanced Parkinson's disease
  12. Synthesis of11C-Labeled Guanidines in Supercritical Ammonia
  13. Positron Emission Tomography with [11C]Deuterium-Deprenyl in Temporal Lobe Epilepsy
  14. [11C]cyanogen bromide in the synthesis of 1,3-di(2-tolyl)-[11C]guanidine
  15. Labelling of proteins with 11C in high specific radioactivity: [11C]albumin and [11C]transferrin
  16. Synthesis of sodium [11C]thiocyanate using [11C]cyanogen bromide
  17. In vitro pet: A new method for imaging neuronal functions in living brain slices
  18. β+-Selective radiodetector for capillary electrophoresis
  19. Synthesis of [11C]- and (13C)-Cyanogen Bromide, Useful Electrophilic Labelling Precursors.
  20. 806 In vivo changes of dopaminergic and cholinergic systems in monkey brain under various anesthesia as evaluated by pet